NuraLogix, developer of contactless health monitoring, unveiled a platform that performs continuous health and vital sign measurements while on a video telemedicine call.
The Anura Telehealth platform, announced at CES 2023, is the latest addition to the Anura platform which uses conventional video cameras to extract facial blood flow information to accurately calculate a host of vital signs and health risk assessments—using only the ubiquitous mobile and desktop devices already in the hands of billions of people.
Nuralogix is the CES 2023 Innovation Award Honoree for Digital Health for the Anura platform that conducts health measurements using a 30 second video scan.
Anura is a video-based contactless health monitoring solution that can measure vital signs and provide health risk assessments using mobile and desktop devices.
The entire Anura platform is powered by NuraLogix’s patented Transdermal Optical Imaging (TOI) technology, a novel form of Remote Photoplethysmography (rPPG). It automatically detects a person’s face, identifies key regions of interest, and extracts blood flow information that is combined with powerful AI data models developed from tens of thousands of patients with multiple health conditions.
Results are delivered within its app, showing information on dozens of health parameters such as heart rate, breathing rate, and cuffless blood pressure. It provides health risk assessments for some of the most prevalent chronic conditions, including type 2 diabetes, hypertension, cardiovascular disease, and mental health.
Filling the Gap in Telehealth
Anura Telehealth is designed to enable true, two-way video telemedicine sessions and enhance remote patient monitoring, making these sessions more useful to both patients and healthcare professionals. The Anura Telehealth platform aims to provide richer interaction between patients and healthcare professionals with the ability to provide real-time information and assist physicians in identifying future health risks.
It is designed for use in the telemedicine, remote patient management and insurance industries. Key features of the platform include:
- Continuous real-time vital sign measurement
- Ability to integrate with video conference software such as Zoom, Teams, Webex, Blue Jeans and more
- Ability to integrate with telehealth software such as Doxy. me
- Customizable interfaces, templates, and reporting to accommodate different use cases
“Post-pandemic telemedicine has increasingly become the norm. While convenient and cost-effective, remote visits have until now lacked the ability for health professionals to carry out the routine health checks they would normally perform in the clinical setting,” says Keith Thompson, MD, FCFP, chief medical officer at NuraLogix. “From heart rate to blood pressure levels, and more, Anura Telehealth allows this to occur in real-time while also helping physicians to leverage the power of AI and its potential to help identity, predict and prevent chronic and acute diseases.”
Anura can assess HbA1c, monitor fasting glucose, and assess the risk of type 2 diabetes, hypertension, and hypertriglyceridemia, the company says. Its research models have currently appeared in 10 global peer-reviewed research publications, with three additional publications in progress covering topics of hypertension, multi-year cardiovascular risk, diabetes, and fatty liver disease. Its latest released models have been proven to predict whether a subject’s HbA1c is greater than 5.7% or their Fasting Blood Glucose is greater than 5.5mmol/L to a clinically accurate level.